Literature DB >> 17678711

IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.

Masanori Maeda1, Yoshiki Yanagawa, Kazuya Iwabuchi, Keita Minami, Yuji Nakamaru, Dai Takagi, Satoshi Fukuda, Kazunori Onoé.   

Abstract

Interleukin (IL)-21 shows pleiotropic effects on the proliferation, differentiation, and effector functions of leukocytes. However, the influence of IL-21 on dendritic cell (DC) activation of natural killer T (NKT) cells has not yet been elucidated. In the present study, we examined the effect of IL-21 on murine myeloid DC ability to induce NKT cell production of interferon-gamma (IFN-gamma) and IL-4. Pretreatment of DCs with IL-21 and alpha-galactosylceramide (alpha-GalCer), an NKT cell-specific ligand, resulted in the enhanced ability of the DCs to induce NKT cell production of IFN-gamma but not IL-4 in vitro compared to DCs pretreated with alpha-GalCer alone. A similar effect of IL-21 was observed when DCs pretreated with IL-21 and alpha-GalCer in vitro were transferred into naïve mice. Direct administration of IL-21 to the mice also enhanced IFN-gamma production after injection of alpha-GalCer. Thus, IL-21 can modify DC ability to selectively enhance NKT cell production of IFN-gamma upon stimulation with alpha-GalCer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678711     DOI: 10.1016/j.imbio.2007.03.007

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

Review 1.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

2.  A pathogenetic role for IL-21 in primary Sjögren syndrome.

Authors:  Seung-Ki Kwok; Jennifer Lee; Di Yu; Kwi Young Kang; Mi-La Cho; Hae-Rim Kim; Ji Hyeon Ju; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Nat Rev Rheumatol       Date:  2015-01-13       Impact factor: 20.543

Review 3.  Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus.

Authors:  Jing Li; Hai-Feng Pan; Han Cen; Jing Tian; Yan Ma; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

4.  A polymorphism within IL21R confers risk for systemic lupus erythematosus.

Authors:  Ryan Webb; Joan T Merrill; Jennifer A Kelly; Andrea Sestak; Kenneth M Kaufman; Carl D Langefeld; Julie Ziegler; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Graciela S Alarcón; Luis M Vilá; Marta E Alarcón-Riquelme; Judith A James; Gary S Gilkeson; Chaim O Jacob; Kathy L Moser; Patrick M Gaffney; Timothy J Vyse; Swapan K Nath; Peter Lipsky; John B Harley; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2009-08

5.  The mechanism of development of acute lung injury in lethal endotoxic shock using alpha-galactosylceramide sensitization.

Authors:  G Tumurkhuu; N Koide; J Dagvadorj; A Morikawa; F Hassan; S Islam; Y Naiki; I Mori; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2008-02-25       Impact factor: 4.330

6.  Interleukin-21 (IL-21) Downregulates Dendritic Cell Cytokine Responses to Helicobacter pylori and Modulates T Lymphocyte IL-17A Expression in Peyer's Patches during Infection.

Authors:  Sharia Yasmin; Beverly R E A Dixon; Danyvid Olivares-Villagómez; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

7.  IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury.

Authors:  Li Li; Liping Huang; Amy L Vergis; Hong Ye; Amandeep Bajwa; Vivek Narayan; Robert M Strieter; Diane L Rosin; Mark D Okusa
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

8.  Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1.

Authors:  Mingrong Cheng; Kangkang Zhi; Xiaoyan Gao; Bing He; Yingchun Li; Jiang Han; Zhiping Zhang; Yan Wu
Journal:  Mol Cancer       Date:  2013-12-18       Impact factor: 27.401

9.  IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.

Authors:  Kesley Attridge; Rupert Kenefeck; Lukasz Wardzinski; Omar S Qureshi; Chun Jing Wang; Claire Manzotti; Klaus Okkenhaug; Lucy S K Walker
Journal:  J Immunol       Date:  2014-01-27       Impact factor: 5.422

Review 10.  iNKT: A new avenue for CAR-based cancer immunotherapy.

Authors:  Yilin Liu; Gang Wang; Dafei Chai; Yuanyuan Dang; Junnian Zheng; Huizhong Li
Journal:  Transl Oncol       Date:  2022-01-18       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.